← Open Payments lookup

KATHLEEN BREWER: Open Payments

NPI 1720497951 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$739 in 40 payments from 11 companies in 2025. Trend: 2023 $905 · 2024 $896 · 2025 $739

Food & beverage: $739
CompanyPaymentsAmount
PFIZER INC.11$177
Boehringer Ingelheim Pharmaceuticals, Inc.4$98
Alnylam Pharmaceuticals Inc.5$83
Merck Sharp & Dohme LLC4$80
Novartis Pharmaceuticals Corporation4$70
Philips North America LLC3$54
BridgeBio Pharma, Inc.3$51
Bayer Healthcare Pharmaceuticals Inc.2$39
AstraZeneca Pharmaceuticals LP2$33
United Therapeutics Corporation1$32

Products named: JARDIANCE, VYNDAQEL, AMVUTTRA, ELIQUIS, LEQVIO, VERQUVO, Attruby, Kerendia.

Industry payments across MS — which companies pay providers there.